D B Calne. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antiparkinson Agents/adverse effectsAntiparkinson Agents/therapeutic useClinical Trials as TopicDrug Therapy, CombinationHumansLevodopa/therapeutic useMonoamine Oxidase Inhibitors/adverse effectsMonoamine Oxidase Inhibitors/therapeutic useNeuroprotective Agents/adverse effectsNeuroprotective Agents/therapeutic useParkinson Disease/drug therapyParkinson Disease/mortalitySelegiline/adverse effectsSelegiline/therapeutic useTreatment FailureUnited Kingdom
Substances: See more » Antiparkinson AgentsMonoamine Oxidase InhibitorsNeuroprotective AgentsSelegilineLevodopa
Year: 1995 PMID: 8555790 PMCID: PMC2551489 DOI: 10.1136/bmj.311.7020.1583
Source DB: PubMed Journal: BMJ ISSN: 0959-8138